• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ceiling respiratory depression by dezocine.

作者信息

Romagnoli A, Keats A S

出版信息

Clin Pharmacol Ther. 1984 Mar;35(3):367-73. doi: 10.1038/clpt.1984.45.

DOI:10.1038/clpt.1984.45
PMID:6421529
Abstract

Dezocine in equianalgesic intravenous doses depressed respiratory response to CO2 breathing of six healthy subjects to approximately the same degree as morphine but with a more rapid onset and higher peak depression. The depression was dose related up to 30 mg/70 kg but was not increased by an additional 10 mg/70 kg dose. Its duration of effect was approximately the same as that of morphine. Respiratory depression by dezocine was promptly and almost completely antagonized by 0.4 mg naloxone, but antagonism lasted less than 1 hr. Healthy subjects found dezocine less pleasant than morphine and after large doses reported sensations suggestive of psychotomimetic effects. A ceiling effect for respiratory depression has now been demonstrated for three agonist-antagonist analgesics: nalorphine, nalbuphine, and dezocine. It is not yet clear to what extent this is a general characteristic of agonist-antagonist analgesics.

摘要

相似文献

1
Ceiling respiratory depression by dezocine.
Clin Pharmacol Ther. 1984 Mar;35(3):367-73. doi: 10.1038/clpt.1984.45.
2
Ventilatory and analgesic effects of dezocine in humans.
Anesthesiology. 1984 Dec;61(6):716-22. doi: 10.1097/00000542-198412000-00015.
3
Ceiling effect for respiratory depression by nalbuphine.纳布啡引起呼吸抑制的天花板效应。
Clin Pharmacol Ther. 1980 Apr;27(4):478-85. doi: 10.1038/clpt.1980.67.
4
Anesthetic potency of dezocine and its interaction with morphine in rats.
Anesth Analg. 1983 Oct;62(10):899-902.
5
Serial intravenous doses of dezocine, morphine, and nalbuphine in the management of postoperative pain for outpatients.门诊患者术后疼痛管理中地佐辛、吗啡和纳布啡的静脉连续给药剂量
Anesth Analg. 1993 Sep;77(3):533-9. doi: 10.1213/00000539-199309000-00018.
6
Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.混合阿片类激动剂/拮抗剂地佐辛的辨别性刺激效应:μ和δ阿片类激动剂的交叉替代作用
J Pharmacol Exp Ther. 1997 Dec;283(3):1009-17.
7
Intravenous dezocine for postoperative pain: a double-blind, placebo-controlled comparison with morphine.静脉注射地佐辛用于术后镇痛:与吗啡的双盲、安慰剂对照比较
J Clin Pharmacol. 1986 Apr;26(4):275-80. doi: 10.1002/j.1552-4604.1986.tb03523.x.
8
Dezocine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.地佐辛。对其药效学、药代动力学特性及治疗效果的初步综述。
Drugs. 1989 Aug;38(2):226-48. doi: 10.2165/00003495-198938020-00005.
9
Assessment of dezocine for morphine-like subjective effects and miosis.
Clin Pharmacol Ther. 1985 Nov;38(5):544-8. doi: 10.1038/clpt.1985.221.
10
Subjective, behavioral, and physiologic responses to intravenous dezocine in healthy volunteers.
Anesth Analg. 1992 Apr;74(4):523-30. doi: 10.1213/00000539-199204000-00010.

引用本文的文献

1
Dezocine Exerts Analgesic Effects in Chronic Pain by Activation of κ- and μ-Opioid Receptors and Inhibition of Norepinephrine and Serotonin Reuptake.地佐辛通过激活κ-和μ-阿片受体以及抑制去甲肾上腺素和血清素再摄取对慢性疼痛发挥镇痛作用。
Pain Res Manag. 2025 Apr 4;2025:5656675. doi: 10.1155/prm/5656675. eCollection 2025.
2
Revisiting dezocine for opioid use disorder: A narrative review of its potential abuse liability.重新审视地佐辛用于阿片类药物使用障碍:对其潜在滥用倾向的叙述性综述。
CNS Neurosci Ther. 2024 Sep;30(9):e70034. doi: 10.1111/cns.70034.
3
Dezocine is a Biased Ligand without Significant Beta-Arrestin Activation of the mu Opioid Receptor.
地佐辛是一种对μ阿片受体无显著β-抑制蛋白激活作用的偏向性配体。
Transl Perioper Pain Med. 2022;9(1):424-429. Epub 2022 Mar 1.
4
Dezocine Has the Potential to Regulate the Clinical and Biological Features of Tumors.地佐辛有可能调节肿瘤的临床和生物学特征。
Drug Des Devel Ther. 2022 Apr 20;16:1121-1129. doi: 10.2147/DDDT.S356863. eCollection 2022.
5
Dezocine as a potent analgesic: overview of its pharmacological characterization.地左辛作为一种强效镇痛药:其药理学特征概述。
Acta Pharmacol Sin. 2022 Jul;43(7):1646-1657. doi: 10.1038/s41401-021-00790-6. Epub 2021 Nov 4.
6
National drug utilization trend of analgesics in China: an analysis of procurement data at 793 public hospitals from 2013 to 2018.中国镇痛药的全国药物利用趋势:对2013年至2018年793家公立医院采购数据的分析
J Pharm Policy Pract. 2021 May 25;14(1):45. doi: 10.1186/s40545-021-00325-8.
7
Dezocine regulates the malignant potential and aerobic glycolysis of liver cancer targeting Akt1/GSK-3β pathway.地佐辛通过靶向Akt1/GSK-3β信号通路调控肝癌的恶性潜能及有氧糖酵解。
Ann Transl Med. 2020 Apr;8(7):480. doi: 10.21037/atm.2020.03.28.
8
Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist.地佐辛的药理学特征:一种强效的阿片类镇痛药,作为 κ 部分激动剂和 μ 部分激动剂。
Sci Rep. 2018 Sep 20;8(1):14087. doi: 10.1038/s41598-018-32568-y.
9
Dezocine exhibits antihypersensitivity activities in neuropathy through spinal μ-opioid receptor activation and norepinephrine reuptake inhibition.地佐辛通过脊髓 μ 阿片受体激活和去甲肾上腺素再摄取抑制在神经病变中表现出抗超敏反应活性。
Sci Rep. 2017 Feb 23;7:43137. doi: 10.1038/srep43137.
10
Adverse effects of opioid agonists and agonist-antagonists in anaesthesia.阿片类激动剂和激动-拮抗剂在麻醉中的不良反应。
Drug Saf. 1998 Sep;19(3):173-89. doi: 10.2165/00002018-199819030-00002.